Chemistry of Heterocyclic Compounds

, Volume 43, Issue 7, pp 863–870 | Cite as

4-Hydroxy-2-quinolones. 122. 1-Hydroxy-3-oxo-5,6-dihydro-3H-pyrrolo[3,2,1-ij]-quinoline-2-carboxylic acid hetarylamides as potential antitubercular agents

  • I. V. Ukrainets
  • E. V. Mospanova
  • L. V. Sidorenko
Article
Received:

Abstract

An improved method is reported for the synthesis of a series of 1-hydroxy-3-oxo-5,6-dihydro-3H-pyrrolo[3,2,1-ij]quinoline-2-carboxylic acid hetarylamides. The antitubercular activity of all of the compounds prepared has been studied. The structure-biological activity dependence revealed is discussed.

Keywords

hetarylamides 4-hydroxy-2-oxoquinoline-3-carboxylic acids amidation antitubercular activity 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    I. V. Ukrainets, N. L. Bereznyakova, and E. V. Mospanova, Khim. Geterotsikl. Soedin., 1015 (2007). [Chem. Heterocycl. Comp., 43, 856 (2007)].Google Scholar
  2. 2.
    WHO Web Site. Links for an Overview of Tuberculosis Worldwide. http://www.who.int/tb/en/
  3. 3.
    L. S. Efferen, Curr. Opin. Pulm. Med., 3, 131 (1997).CrossRefGoogle Scholar
  4. 4.
    A. Fraser, M. Paul, A. Attamna, and L. Leibovici, Int. J. Tuberc. Lung. Dis., 10, 19 (2006).Google Scholar
  5. 5.
    A. Faustini, A. J. Hall, and C. A. Perucci, Thorax, 61, 158 (2006).CrossRefGoogle Scholar
  6. 6.
    A. Kutyrev and T. Kappe, J. Heterocycl. Chem., 34, 969 (1997).CrossRefGoogle Scholar
  7. 7.
    I. V. Ukrainets, L. V. Sidorenko, O. V. Gorokhova, E. V. Mospanov, and O. V. Shishkin, Khim. Geterotsikl. Soedin., 718 (2006). [Chem. Heterocycl. Comp., 42, 631 (2006)].Google Scholar
  8. 8.
    L. B. Heifets, in: L. B. Heifets (editor), Drug Susceptibility in the Chemotherapy of Mycobacterial Infections, CRC Press, Boca Raton (1991), p. 89.Google Scholar
  9. 9.
    C. B. Inderleid and K. A. Nash, in: V. Lorian (editor), Antibiotics in Laboratory Medicine, Williams and Wilkins, Baltimore (1996), p. 127.Google Scholar
  10. 10.
    S. H. Siddiqui, in: H. D. Isenberg (editor), Clinical Microbiology Procedures Handbook, Vol. 1, American Society for Microbiology, Washington D.C. (1992), p. 5.14.2Google Scholar
  11. 11.
    I. V. Ukrainets, S. A. El Kayal, O. V. Gorokhova, L. V. Sidorenko, and T. V. Alexeeva, Visnyk Farmatsii, No. 1 (37), 12 (2004).Google Scholar
  12. 12.
    I. V. Ukrainets, S. A. El Kayal, O. V. Gorokhova, and L. V. Sidorenko, Farm. Zhurn., No. 4, 47 (2004).Google Scholar
  13. 13.
    L. A. Petrushova, Dissertation of Candidates in Pharm. Sci., Kharkiv (2006).Google Scholar
  14. 14.
    Amjad Aby Sharkh, Dissertation of Candidates in Pharm. Sci., Kharkiv (2003).Google Scholar
  15. 15.
    G. A. Mokrushina, V. N. Charushin, and O. N. Chupakhin, Khim.-Farm. Zh., 29, No. 9, 5 (1995).Google Scholar

Copyright information

© Springer Science+Business Media, Inc. 2007

Authors and Affiliations

  • I. V. Ukrainets
    • 1
  • E. V. Mospanova
    • 1
  • L. V. Sidorenko
    • 1
  1. 1.National University of PharmacyKharkivUkraine

Personalised recommendations